Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruurd Torensma

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Blood|May 10, 2005
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibodyPaul J Tacken, I Jolanda M de Vries, Karlijn Gijzen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Monocyte cell surface glycosaminoglycans positively modulate IL-4-induced differentiation toward dendritic cellsEls den Dekker, Sander Grefte, Tonnie Huijs, et al.
BMC Immunology|December 19, 2012
Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndromeHetty Prinsen, I Jolanda M de Vries, Ruurd Torensma, et al.
Immunology Letters|August 30, 2003
Analysis of dendritic cell trafficking using EGFP-transgenic miceAndreas A O Eggert, Robbert van der Voort, Ruurd Torensma, et al.
Journal of Cellular and Molecular Medicine|March 4, 2010
Toll-like receptor triggering in cord blood mesenchymal stem cellsLieke C J van den Berk, Bastiaan J H Jansen, Kim G C Siebers-Vermeulen, et al.
Plos Pathogens|March 14, 2009
The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunityAnnemiek B van Spriel, Mariam Sofi, Kate H Gartlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patientsI Jolanda M de Vries, W Joost Lesterhuis, Nicole M Scharenborg, et al.
Cancer Immunology, Immunotherapy : CII|November 12, 2010
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide usedW Joost Lesterhuis, Gerty Schreibelt, Nicole M Scharenborg, et al.
Cancer Research|June 22, 2016
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell VaccinesGhaith Bakdash, Sonja I Buschow, Mark A J Gorris, et al.
Human Vaccines & Immunotherapeutics|May 22, 2015
Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigueHetty Prinsen, Hanneke W M van Laarhoven, Jeanette M Pots, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Blood|May 10, 2005
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibodyPaul J Tacken, I Jolanda M de Vries, Karlijn Gijzen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Monocyte cell surface glycosaminoglycans positively modulate IL-4-induced differentiation toward dendritic cellsEls den Dekker, Sander Grefte, Tonnie Huijs, et al.
BMC Immunology|December 19, 2012
Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndromeHetty Prinsen, I Jolanda M de Vries, Ruurd Torensma, et al.
Immunology Letters|August 30, 2003
Analysis of dendritic cell trafficking using EGFP-transgenic miceAndreas A O Eggert, Robbert van der Voort, Ruurd Torensma, et al.
Journal of Cellular and Molecular Medicine|March 4, 2010
Toll-like receptor triggering in cord blood mesenchymal stem cellsLieke C J van den Berk, Bastiaan J H Jansen, Kim G C Siebers-Vermeulen, et al.
Plos Pathogens|March 14, 2009
The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunityAnnemiek B van Spriel, Mariam Sofi, Kate H Gartlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patientsI Jolanda M de Vries, W Joost Lesterhuis, Nicole M Scharenborg, et al.
Cancer Immunology, Immunotherapy : CII|November 12, 2010
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide usedW Joost Lesterhuis, Gerty Schreibelt, Nicole M Scharenborg, et al.
Cancer Research|June 22, 2016
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell VaccinesGhaith Bakdash, Sonja I Buschow, Mark A J Gorris, et al.
Human Vaccines & Immunotherapeutics|May 22, 2015
Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigueHetty Prinsen, Hanneke W M van Laarhoven, Jeanette M Pots, et al.
Pageof 9